Product NDC: | 0409-9094 |
Proprietary Name: | Fentanyl Citrate |
Non Proprietary Name: | FENTANYL CITRATE |
Active Ingredient(s): | 50 ug/mL & nbsp; FENTANYL CITRATE |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-9094 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019115 |
Marketing Category: | NDA |
Start Marketing Date: | 20111123 |
Package NDC: | 0409-9094-25 |
Package Description: | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-9094-25) > 5 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 0409-9094-25 |
Proprietary Name | Fentanyl Citrate |
Package Description | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-9094-25) > 5 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 0409-9094 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | FENTANYL CITRATE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20111123 |
Marketing Category Name | NDA |
Labeler Name | Hospira, Inc. |
Substance Name | FENTANYL CITRATE |
Strength Number | 50 |
Strength Unit | ug/mL |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |